Your browser doesn't support javascript.
loading
Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.
Wong, Nelson K Y; Llaurado Fernandez, Marta; Kommoss, Felix K F; Praveen Kumar, Pooja; Kim, Hannah; Liu, Jiahui; Zhang, Guihua; Coatham, Mackenzie; Lin, Yen-Yi; Haegert, Anne M; Volik, Stanislav; Le Bihan, Stephane; Collins, Colin C; Fu, Yangxin; Postovit, Lynne M; von Deimling, Andreas; Wu, Rebecca; Xue, Hui; Wang, Yuzhuo; Köbel, Martin; Carey, Mark S; Lee, Cheng-Han.
Affiliation
  • Wong NKY; Department of Experimental Therapeutics, BC Cancer, Vancouver, British Columbia, Canada.
  • Llaurado Fernandez M; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.
  • Kommoss FKF; Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Praveen Kumar P; Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, Canada.
  • Kim H; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.
  • Liu J; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
  • Zhang G; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
  • Coatham M; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
  • Lin YY; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • Haegert AM; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • Volik S; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • Le Bihan S; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • Collins CC; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • Fu Y; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
  • Postovit LM; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
  • von Deimling A; Department of Neuropathology, Heidelberg University Hospital and CCU Neuropathology DKFZ, Heidelberg, Germany.
  • Wu R; Department of Experimental Therapeutics, BC Cancer, Vancouver, British Columbia, Canada.
  • Xue H; Department of Experimental Therapeutics, BC Cancer, Vancouver, British Columbia, Canada.
  • Wang Y; Department of Experimental Therapeutics, BC Cancer, Vancouver, British Columbia, Canada.
  • Köbel M; Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Alberta, Canada.
  • Carey MS; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.
  • Lee CH; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada; Department of Laboratory Medicine and Pathology, Royal Alexandra Hospital, Edmonton, Alberta, Canada. Electronic address: chenghanlee@gmail.com.
Gynecol Oncol ; 176: 162-172, 2023 09.
Article in En | MEDLINE | ID: mdl-37556934
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Colorectal Neoplasms / Endometrial Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Colorectal Neoplasms / Endometrial Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article Affiliation country: Canada